The potential of proton magnetic resonance spectroscopy (1H-MRS) in the diagnosis and management of patients with brain tumors

Current Opinion in Oncology

Volumn 14, Issue 3, 2002, Pages 292-298

  Leclerc, Xavier ^a   Huisman, Thierry A G M ^a   Sorensen, A Gregory ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATINE; INOSITOL; LACTIC ACID; LIPID; N ACETYLASPARTIC ACID;

BRAIN BIOPSY; BRAIN MAPPING; BRAIN METABOLISM; BRAIN TUMOR; CANCER DIAGNOSIS; CANCER GRADING; CANCER RADIOTHERAPY; HUMAN; NEUROCHEMISTRY; PATIENT MONITORING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RADIOSURGERY; REVIEW; TECHNIQUE; TREATMENT PLANNING; TUMOR BIOPSY; TUMOR VOLUME;

ADULT; BIOPSY; BRAIN; BRAIN NEOPLASMS; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASM STAGING; PROGNOSIS; PROTONS; SENSITIVITY AND SPECIFICITY;

EID: 0036245455     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-200205000-00007     Document Type: Review

References (55)

1. The independence of nuclear magnetic resonance frequency upon chemical shift
2. Proton MR spectroscopy of the brain
3. Magnetic resonance spectroscopy of the human brain: The anatomic record
4. Proton magnetic resonance spectroscopy in brain tumors: Clinical applications
5. Spectroscopy
6. Proton MR spectroscopy of preoperative diagnostic accuracy: An evaluation of intracranial mass lesions characterized by stereotactic biopsy findings
7. MR-spectroscopy guided target delineation for high-grade gliomas
8. Proton spectroscopy imaging of the human brain using phase array detectors
9. Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer
10. An efficient chemical shift imaging scheme for magnetic resonance-guided neurosurgery
11. Preliminary assessment of turbo spectroscopy imaging for targeting in brain biopsy
12. Short-echo time proton MR spectroscopy in the presence of gadolinium
13. Combined MR spectroscopy and dynamic contrast enhanced MR imaging of human intracranial tumors in vivo
14. 1H chemical shift imaging reveals loss of brain tumor choline signal after administration of a Gd-contrast
15. Magnetic resonance spectroscopy and the practicing neurologist
16. 1H MR spectroscopy of human brain tumors in vivo
17. Metabolite abnormalities in progressive multifocal leukoencephalopathy by proton magnetic resonance spectroscopy
18. Accuracy of single-voxel proton MR spectroscopy distinguishing neoplastic from non-neoplastic lesions of brain
19. Human brain tumors: Assessment with in vivo MR spectroscopy
20. Proton MR spectroscopy and neuropsychological testing in adrenoleukodystrophy
21. Toxoplasmosis and primary central nervous system lymphoma in HIV infection: Diagnosis with MR spectroscopy
22. The proton NMR spectrum in acute EAE: The significance of the change in Oho:Cr ratio
23. Single voxel proton MR spectroscopy of nonneoplastic brain lesions suggestive of a neoplasm
24. Spectroscopy increase in choline signal is a nonspecific marker for differentiation of infective/inflammatory from neoplastic lesions of the brain
25. Prospective evaluation of in vivo proton MR spectroscopy in differentiation of similar appearing intracranial cystic lesions
26. Discrimination of brain abscess and cystic tumor by in vivo proton magnetic resonance spectroscopy
27. Characterization of intracranial mass lesions with in vivo proton MR spectroscopy
28. Neuroimaging and cartography: Mapping brain tumors
29. Differentiation between high-grade glioma and metastatic brain tumor using single-voxel proton MR spectroscopy
30. Proton MR spectroscopy of craniopharyngiomas
31. Lhermitte-Duclos disease: Assessment with MR imaging, positron emission tomography, single-photon emission CT, and MR spectroscopy
32. Proton magnetic resonance spectroscopy of choroid plexus tumors in children
33. Magnetic resonance spectroscopy of brain hemangiopericytomas: High myoinositol concentrations and discrimination from meningiomas
34. Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy
35. 1H- and 31P spectroscopy of primary and recurrent brain tumors in vitro: Malignancy-characteristic profiles of water soluble and lipophilic spectral components
36. Using proton magnetic resonance spectroscopic imaging to predict in vivo the response of recurrent malignant gliomas to tamoxifen chemotherapy
37. Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas
38. Increased choline signal coinciding with malignant degeneration of cerebral gliomas: A serial proton magnetic resonance spectroscopy imaging study
39. Proton magnetic resonance spectroscopy in patients with glial tumors: A multicenter study
40. Improving diagnostic yield in brain biopsy: Coupling spectroscopy targeting with real-time needle placement
41. Correlation of Myo-inositol levels and grading of cerebral astrocytomas
42. In vivo localized single-voxel proton magnetic resonance spectroscopy of intracranial tumors
43. Three-dimensional magnetic resonance spectroscopic imaging of histologically confirmed brain tumors
44. Preoperative proton MR spectroscopy imaging of brain tumors: Correlations with histopathologic analysis of resections specimens
45. Analysis of volume MRI and MR spectroscopic imaging data for the evaluation of patients with brain tumors
46. 1H CSI)-directed stereotactic biopsy
47. A preliminary study of the pronostic value of proton magnetic resonance spectroscopic imaging in gamma knife radiosurgery of recurrent malignant gliomas
48. Serial proton MR spectroscopy imaging of recurrent malignant gliomas after gamma knife radiosurgery
49. Proton MR spectroscopy of suspicious brain lesions after stereotactic radiotherapy
50. Accurate noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy
51. Differentiation of cerebral radiation necrosis from tumor recurrence by proton magnetic resonance spectroscopy
52. Application of proton chemical shift imaging in monitoring of gamma knife radiosurgery on brain tumors
53. Proton magnetic spectroscopic imaging of the child's brain: The response of tumors to treatment
54. An automated technique or the quantificative assessment of 3D-MRSI data from patients with glioma